- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vera Therapeutics Inc (VERA)
Track today's live Vera Therapeutics (VERA) share price, performance and key data on this page with our current NASDAQ:VERA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Vera Therapeutics share price on the NASDAQ exchange. Use the dropdown to switch exchange for the VERA share price, head to our technical summary section, which provides analysis on Vera Therapeutics share price buy/sell indicators using real-time data (or discuss the Vera Therapeutics (VERA) stock price today with other investors in the Vera Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:VERA share price (ISIN: US92337R1014) to enhance your trading decisions with our free investment tools and resources.
What Is the Vera Therapeutics Inc Share Price Today?
The Vera Therapeutics share price today is 31.63.
What Is the Stock Symbol for Vera Therapeutics Inc
The stock symbol (or 'ticker') for Vera Therapeutics Inc is "VERA."
What Stock Exchange Does Vera Therapeutics Inc Trade On?
Vera Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Vera Therapeutics Inc a Good Stock to Buy?
Determining whether Vera Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:VERA share price (ISIN: US92337R1014) to enhance your trading decisions with our free investment tools and resources.
What Is the Vera Therapeutics Inc Share Price Today?
The Vera Therapeutics share price today is 31.63.
What Is the Stock Symbol for Vera Therapeutics Inc
The stock symbol (or 'ticker') for Vera Therapeutics Inc is "VERA."
What Stock Exchange Does Vera Therapeutics Inc Trade On?
Vera Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Vera Therapeutics Inc a Good Stock to Buy?
Determining whether Vera Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.73
32.31
52 wk Range
21.15
56.05
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.7332.31
52 wk Range
21.1556.05
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VERA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
77.29
Upside
+144.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 77.29
(+144.34% Upside)
Earnings
Latest Release
10/08/2026
EPS / Forecast
-1.52 / -1.65
Revenue / Forecast
-- / --
Compare VERA to Peers and Sector
Metrics to compare | VERA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVERAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.7x | −1.7x | −0.4x | |
PEG Ratio | 0.09 | −0.03 | 0.00 | |
Price/Book | 5.6x | 9.3x | 2.6x | |
Price / LTM Sales | - | 8.5x | 3.1x | |
Upside (Analyst Target) | 149.8% | 57.6% | 47.8% | |
Fair Value Upside | Unlock | −4.3% | 6.2% | Unlock |
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Vera Therapeutics (NASDAQ: VERA) Share Price Today?
The Vera Therapeutics stock price today is 31.63 USD.
What Stock Exchange Does Vera Therapeutics (VERA) Trade On?
Vera Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Vera Therapeutics?
The stock symbol (also called a 'ticker') for Vera Therapeutics is "VERA."
What Is the Current Vera Therapeutics Market Capitalisation?
As of today, Vera Therapeutics (NASDAQ: VERA) market cap is 2.08B USD.
What Is Vera Therapeutics's (VERA) Earnings Per Share (TTM)?
The Vera Therapeutics EPS is currently -5.89 (Trailing Twelve Months).
When Is the Next Vera Therapeutics Earnings Date?
Vera Therapeutics's next earnings report will be released on 11/11/2026.
Is VERA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Vera Therapeutics moving averages and other technical indicators, the daily buy/sell signal for VERA stock is Strong Sell.
How Many Times Has Vera Therapeutics Stock Split?
Vera Therapeutics has split 0 times. (See the VERA stock split history page for full effective split date and price information.)
How Many Employees Does Vera Therapeutics Have?
Vera Therapeutics has 361 employees, based on their latest Companies House report.
What is the current trading status of Vera Therapeutics (NASDAQ: VERA)?
As of 15/08/2026, Vera Therapeutics (VERA) is trading at a share price of 31.63 USD, with a previous close of 28.89 USD. The stock has fluctuated within a day range of 29.73 USD to 32.31 USD, while its 52-week range spans from 21.15 USD to 56.05 USD.
What Is Vera Therapeutics (VERA) Price Target According to Analysts?
The average 12-month price target for Vera Therapeutics is 77.29 USD, with a high estimate of 100 USD and a low estimate of 34 USD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +144.34% Upside potential.
What Is the VERA Premarket Price?
VERA's last pre-market stock price is 30.81 USD. The pre-market share volume is 826,800.00, and the stock has decreased by 1.92, or 6.65%.
What Is the VERA After Hours Price?
VERA's last after hours stock price is 31.68 USD, the stock has decreased by 0.05, or 0.16%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.